AMC Stock Price and News: AMC falls as meme stocks take a beating to close out OPEX week

NYSE:AMC fell by 4.00% on Friday, as the broader markets tumbled to close the week.
The fallout from the GameStop squeeze continues as Roaring Kitty’s former employer is sued.
AMC is preparing for a pent up supply of blockbusters ready to hit theaters.

NYSE:AMC investors were probably thankful that September OPEX week has finally ended, as the stock fell by nearly 15% over the past five days. On Friday, shares of AMC fell a further 4.00% to close out the session at $44.20. The markets saw red from start to finish, as all three major indices plummeted into the weekend. The meme sector did not fare much better, as GameStop (NYSE:GME) dipped by 0.73% and Vinco Ventures (NASDAQ:BBIG) fell by 6.61% during Friday’s session.

Stay up to speed with hot stocks' news!

The fallout from the initial GameStop squeeze in January continued on Friday, as the company MassMutual was sued for over $4 million by securities regulators in the state of Massachusetts. For those who are wondering, MassMutual is the former company that employed r/WallStreetBet legend Roaring Kitty, otherwise known as Keith Gill. The securities regulators sued MassMutual for not properly supervising Gill, who violated protocols by providing investing advice on Reddit. The ordeal provides another grey area between social media usage and what information or advice can be provided on those platforms.

AMC Entertainment Holdings stock

In terms of AMC’s business, movie theaters are about to get hit with a deluge of Hollywood blockbusters that had their releases delayed by COVID-19. Movies such as Dune, the latest James Bond movie No Time to Die, and the Sopranos prequel The Many Saints of Newark are all expected to hit theaters by October. The Venom sequel Let There be Carnage and a new Spider-Man movie in December highlight the superhero offerings for the rest of 2021.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.